» Articles » PMID: 29017857

Administration of 5-methoxyindole-2-carboxylic Acid That Potentially Targets Mitochondrial Dihydrolipoamide Dehydrogenase Confers Cerebral Preconditioning Against Ischemic Stroke Injury

Overview
Date 2017 Oct 12
PMID 29017857
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to investigate a possible role of mitochondrial dihydrolipoamide dehydrogenase (DLDH) as a chemical preconditioning target for neuroprotection against ischemic injury. We used 5-methoxyindole-2-carboxylic acid (MICA), a reportedly reversible DLDH inhibitor, as the preconditioning agent and administered MICA to rats mainly via dietary intake. Upon completion of 4 week's MICA treatment, rats underwent 1h transient ischemia and 24h reperfusion followed by tissue collection. Our results show that MICA protected the brain against ischemic stroke injury as the infarction volume of the brain from the MICA-treated group was significantly smaller than that from the control group. Data were then collected without or with stroke surgery following MICA feeding. It was found that in the absence of stroke following MICA feeding, DLDH activity was lower in the MICA treated group than in the control group, and this decreased activity could be partly due to DLDH protein sulfenation. Moreover, DLDH inhibition by MICA was also found to upregulate the expression of NAD(P)H-ubiquinone oxidoreductase 1(NQO1) via the Nrf2 signaling pathway. In the presence of stroke following MICA feeding, decreased DLDH activity and increased Nrf2 signaling were also observed along with increased NQO1 activity, decreased oxidative stress, decreased cell death, and increased mitochondrial ATP output. We also found that MICA had a delayed preconditioning effect four weeks post MICA treatment. Our study indicates that administration of MICA confers chemical preconditioning and neuroprotection against ischemic stroke injury.

Citing Articles

Impact of NQO1 dysregulation in CNS disorders.

Yuhan L, Khaleghi Ghadiri M, Gorji A J Transl Med. 2024; 22(1):4.

PMID: 38167027 PMC: 10762857. DOI: 10.1186/s12967-023-04802-3.


Roles of Dihydrolipoamide Dehydrogenase in Health and Disease.

Yan L, Wang Y Antioxid Redox Signal. 2023; 39(10-12):794-806.

PMID: 37276180 PMC: 10615065. DOI: 10.1089/ars.2022.0181.


The pathogenesis of DLD-mediated cuproptosis induced spinal cord injury and its regulation on immune microenvironment.

Li C, Wu C, Ji C, Xu G, Chen J, Zhang J Front Cell Neurosci. 2023; 17:1132015.

PMID: 37228705 PMC: 10203164. DOI: 10.3389/fncel.2023.1132015.


Renal-Protective Roles of Lipoic Acid in Kidney Disease.

Kamt S, Liu J, Yan L Nutrients. 2023; 15(7).

PMID: 37049574 PMC: 10097220. DOI: 10.3390/nu15071732.


Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD-Dependent Enzymes and Plant-Derived Natural Products.

Iskander A, Yan L Biomolecules. 2022; 12(8).

PMID: 36008971 PMC: 9405866. DOI: 10.3390/biom12081078.


References
1.
Cai Z, Yan L . Protein Oxidative Modifications: Beneficial Roles in Disease and Health. J Biochem Pharmacol Res. 2013; 1(1):15-26. PMC: 3646577. View

2.
Gusdon A, Votyakova T, Reynolds I, Mathews C . Nuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species production. J Biol Chem. 2006; 282(8):5171-9. DOI: 10.1074/jbc.M609367200. View

3.
Yan L, Liu L, Forster M . Reversible inactivation of dihydrolipoamide dehydrogenase by Angeli's salt. Sheng Wu Wu Li Hsueh Bao. 2012; 28(4):341-350. PMC: 3490496. View

4.
Strausberg R, Feingold E, Grouse L, Derge J, Klausner R, Collins F . Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A. 2002; 99(26):16899-903. PMC: 139241. DOI: 10.1073/pnas.242603899. View

5.
Chouchani E, Pell V, James A, Work L, Saeb-Parsy K, Frezza C . A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury. Cell Metab. 2016; 23(2):254-63. DOI: 10.1016/j.cmet.2015.12.009. View